Identifying potential new opportunities to advance care for those impacted by rare endocrine diseases.
Our work in rare endocrinology builds upon our strong foundation in bone metabolism, positioning us to build on established expertise to advance science for a community with significant unmet medical needs.
We are driven by our commitment to deliver transformational therapies on behalf of the rare disease community to advance research of rare endocrine diseases and contribute to greater scientific understanding that will lead to new treatment options.
By combining our clinical development and commercial expertise with AstraZeneca's global infrastructure, we seek to identify new opportunities to advance care for those impacted by these conditions and reach more people in need.
Researching and developing innovative treatments that aim to target the underlying causes of rare bone disorders.
Following the science to develop and evaluate potential innovative treatment options to help people living with rare cardiology conditions.
Working to improve potential outcomes for more people living with rare haematological diseases worldwide.
Enhancing the understanding of rare renal diseases and accelerating the development of potential therapies.
Striving to advance scientific understanding in rare neurology and to accelerate the development of potential life-changing treatments.
Striving to advance scientific understanding of rare cancers to bring new solutions.
Veeva ID: GL/ALL/0034